These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8335511)

  • 1. Lack of effect of ketoprofen on the pharmacokinetics of pefloxacin and ofloxacin.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    J Antimicrob Chemother; 1993 May; 31(5):805-6. PubMed ID: 8335511
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males].
    Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Pathol Biol (Paris); 1993 Apr; 41(4):379-84. PubMed ID: 8233639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.
    Giamarellou H; Kanellas D; Kavouklis E; Petrikkos G; Gabriel L
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):293-7. PubMed ID: 8513819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy activity and pharmacokinetics of the fluoroquinolones generics Ofloxacin-PhPO and Pefloxacin-genova].
    Ptitsina SN; Bobrov VI; Borisov MM
    Antibiot Khimioter; 2007; 52(6):13-6. PubMed ID: 18476469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin].
    Nordmann P; Jarlier V
    Presse Med; 1990 Sep 1-8; 19(28):1321-5. PubMed ID: 2145562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of three newer quinolones in pregnant and lactating women.
    Giamarellou H; Kolokythas E; Petrikkos G; Gazis J; Aravantinos D; Sfikakis P
    Am J Med; 1989 Nov; 87(5A):49S-51S. PubMed ID: 2589384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract]   [Full Text] [Related]  

  • 11. Stereoselectivity of ofloxacin intestinal transport in the rat.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Drugs; 1995; 49 Suppl 2():333-4. PubMed ID: 8549352
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
    Reynaud AE; Espaze EP; Coste-Burel M; Richet H
    Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier-mediated system for pefloxacin uptake in human monocytes.
    Mémin E; Panteix G; Revol A
    J Antimicrob Chemother; 1997 Aug; 40(2):263-8. PubMed ID: 9301993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
    D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
    J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ofloxacin for the treatment of leprosy.
    Ji B; Grosset J
    Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
    Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.